With Few New Clotting Cases, Johnson & Johnson Pause Could Be Lifted Soon
Top federal health officials said in interviews this week that the number of rare blood clotting disorders in recipients of the Johnson & Johnson vaccine has remained small.
- Next story When do Memorial Day appliance sales start?
- Previous story Trial tests intervention to reduce sedentary time in patients with kidney disease
Explore more
- Nicaraguan presidential challenger placed under house arrest
Nicaraguan presidential challenger Cristiana Chamorro has been placed under house arrest and... - Signs of Economic Hope Are Growing, Some With Superlatives
Soaring retail sales and a sharp drop in jobless claims are the... - Antioxidant protein inside the cell worsens inflammation outside
A protein that provides essential protection against free radicals inside the cell... - How to confront and overcome the discomfort of starting something new
COVID-19 catapulted our society on a mass scale into the online environment,... - Malcolm Gladwell on the Hard Decisions of War
Gladwell’s “The Bomber Mafia” looks at the air campaign against Japan in... - Trump allies seize on ballot issue to push false election claims
Trump and his allies are seizing on an election audit in New... - The mystery of ‘long COVID’: What we know so far
Most people who get COVID suffer the common symptoms of fever, cough... - Outcomes poorer with six versus 12 weeks of antibiotics for PJI
(HealthDay)—Antibiotic therapy for six weeks is inferior to 12 weeks of therapy... - Newsom’s Plan: California’s Middle-Class Taxpayers Could Get a Rebate Under Proposal
Faced with a large state surplus and a looming recall election, Gov.... - How Brazil gambled on unproven drugs to fight Covid-19
Brazilian President Jair Bolsonaro has long been a champion of drugs chloroquine...